Performance analysis of Cocrystal Pharma (COCP)
Annual Return
Over the past 3 years, COCP has had an average annual return of -23.13%, underperforming the benchmark SPY, which returned +22.45% annual.
Over the past 5 years, COCP has had an average annual return of -41.71%, underperforming the benchmark SPY, which returned +13.88% annual.
Over the past 10 years, COCP has had an average annual return of -41.84%, underperforming the benchmark SPY, which returned +15.45% annual.
Since May 19, 2011, COCP has had an average annual return of -39.65%, underperforming the benchmark SPY, which returned +14.13% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0% | -50.00% | +11.11% | -10.00% | -74.36% | -52.44% | +173.33% | -86.24% | -40.11% | -48.00% | -56.74% | +111.78% |
| 2014 | 2013 | 2012 | 2011 | ||||||||
| -34.36% | -80.30% | -11.69% | -33.09% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0% | +0% | +0% | +40% | -14.29% | -16.67% | +0% | ||||||
| 2025 | +0% | -10.00% | -22.22% | +14.29% | +12.50% | -11.11% | +12.50% | -11.11% | -25.00% | +0% | -16.67% | +0% | -50.00% |
| 2024 | -11.11% | -12.50% | +0% | +14.29% | +37.50% | +9.09% | -16.67% | -10.00% | +0% | +0% | +11.11% | +0% | +11.11% |
| 2023 | +40% | -28.57% | +0% | +30% | -15.38% | +9.09% | +8.33% | +15.38% | -40.00% | +0% | +11.11% | -10.00% | -10.00% |
| 2022 | -12.82% | -2.94% | -0% | -15.15% | -14.29% | +4.17% | -4.00% | -0% | -25.00% | -27.78% | +7.69% | -28.57% | -74.36% |
| 2021 | +26.83% | -8.65% | -11.58% | -14.29% | -5.56% | +11.76% | -7.89% | +1.43% | -9.86% | -15.63% | -0% | -27.78% | -52.44% |
| 2020 | +26.67% | +113.16% | -46.91% | +32.56% | +3.51% | +55.93% | +10.87% | -37.25% | -12.50% | -8.93% | +156.86% | -37.40% | +173.33% |
| 2019 | -19.27% | -0.57% | -5.71% | -6.06% | -10.32% | +2.16% | -2.82% | +0.72% | -10.79% | -63.71% | -31.11% | -3.23% | -86.24% |
| 2018 | -29.95% | -1.18% | +43.25% | -64.54% | +8.59% | +59.71% | +13.51% | -11.11% | -32.14% | -26.32% | +89.29% | +2.83% | -40.11% |
| 2017 | +1.57% | -25.88% | -6.83% | +0% | -25.87% | +9.89% | -9.00% | +25% | +7.91% | -6.52% | -0.87% | -20.00% | -48.00% |
Drawdown analysis of Cocrystal Pharma (COCP)
The maximum drawdown for the COCP was -99.96%, occurring on Feb 5, 2026. This drawdown has not yet recovered.
The current COCP drawdown is -99.95%.
Since May 19, 2011 COCP has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.96% | May 19, 2011 | 3700 | Feb 5, 2026 | Ongoing | Ongoing | Ongoing |